Fusion High Frame Rate OCT and AI-Driven FFR for the Assessment of Coronary Lesions (Raywatt)

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Philips
• Grant Support/Research Contract - Daiichi-Sankyo/Elil Lilly and Company; Samjin; Yuhan
• Equity/Stock(s)/Options - Raywatt